Rhinopithecus roxellana (golden snub-nosed monkey): 104671624
Help
Entry
104671624 CDS
T03989
Gene name
PLCG2
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
rro
Rhinopithecus roxellana (golden snub-nosed monkey)
Pathway
rro00562
Inositol phosphate metabolism
rro01100
Metabolic pathways
rro01521
EGFR tyrosine kinase inhibitor resistance
rro04012
ErbB signaling pathway
rro04014
Ras signaling pathway
rro04020
Calcium signaling pathway
rro04062
Chemokine signaling pathway
rro04064
NF-kappa B signaling pathway
rro04066
HIF-1 signaling pathway
rro04070
Phosphatidylinositol signaling system
rro04072
Phospholipase D signaling pathway
rro04360
Axon guidance
rro04370
VEGF signaling pathway
rro04380
Osteoclast differentiation
rro04611
Platelet activation
rro04613
Neutrophil extracellular trap formation
rro04625
C-type lectin receptor signaling pathway
rro04650
Natural killer cell mediated cytotoxicity
rro04662
B cell receptor signaling pathway
rro04664
Fc epsilon RI signaling pathway
rro04666
Fc gamma R-mediated phagocytosis
rro04670
Leukocyte transendothelial migration
rro04722
Neurotrophin signaling pathway
rro04750
Inflammatory mediator regulation of TRP channels
rro04919
Thyroid hormone signaling pathway
rro04933
AGE-RAGE signaling pathway in diabetic complications
rro04935
Growth hormone synthesis, secretion and action
rro05167
Kaposi sarcoma-associated herpesvirus infection
rro05169
Epstein-Barr virus infection
rro05170
Human immunodeficiency virus 1 infection
rro05171
Coronavirus disease - COVID-19
rro05200
Pathways in cancer
rro05205
Proteoglycans in cancer
rro05206
MicroRNAs in cancer
rro05214
Glioma
rro05223
Non-small cell lung cancer
rro05225
Hepatocellular carcinoma
Module
rro_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
rro00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
104671624 (PLCG2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
104671624 (PLCG2)
04014 Ras signaling pathway
104671624 (PLCG2)
04370 VEGF signaling pathway
104671624 (PLCG2)
04064 NF-kappa B signaling pathway
104671624 (PLCG2)
04066 HIF-1 signaling pathway
104671624 (PLCG2)
04020 Calcium signaling pathway
104671624 (PLCG2)
04070 Phosphatidylinositol signaling system
104671624 (PLCG2)
04072 Phospholipase D signaling pathway
104671624 (PLCG2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
104671624 (PLCG2)
04613 Neutrophil extracellular trap formation
104671624 (PLCG2)
04625 C-type lectin receptor signaling pathway
104671624 (PLCG2)
04650 Natural killer cell mediated cytotoxicity
104671624 (PLCG2)
04662 B cell receptor signaling pathway
104671624 (PLCG2)
04664 Fc epsilon RI signaling pathway
104671624 (PLCG2)
04666 Fc gamma R-mediated phagocytosis
104671624 (PLCG2)
04670 Leukocyte transendothelial migration
104671624 (PLCG2)
04062 Chemokine signaling pathway
104671624 (PLCG2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
104671624 (PLCG2)
04919 Thyroid hormone signaling pathway
104671624 (PLCG2)
09156 Nervous system
04722 Neurotrophin signaling pathway
104671624 (PLCG2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
104671624 (PLCG2)
09158 Development and regeneration
04360 Axon guidance
104671624 (PLCG2)
04380 Osteoclast differentiation
104671624 (PLCG2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
104671624 (PLCG2)
05206 MicroRNAs in cancer
104671624 (PLCG2)
05205 Proteoglycans in cancer
104671624 (PLCG2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
104671624 (PLCG2)
05214 Glioma
104671624 (PLCG2)
05223 Non-small cell lung cancer
104671624 (PLCG2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
104671624 (PLCG2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
104671624 (PLCG2)
05171 Coronavirus disease - COVID-19
104671624 (PLCG2)
05167 Kaposi sarcoma-associated herpesvirus infection
104671624 (PLCG2)
05169 Epstein-Barr virus infection
104671624 (PLCG2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
104671624 (PLCG2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
rro04131
]
104671624 (PLCG2)
Enzymes [BR:
rro01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
104671624 (PLCG2)
Membrane trafficking [BR:
rro04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
104671624 (PLCG2)
Endocytosis
Macropinocytosis
Phospholipase C
104671624 (PLCG2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
C2
SH3_9
PH
SH3_2
PH_12
PH_14
EF-hand_like
GDPD
Motif
Other DBs
NCBI-GeneID:
104671624
NCBI-ProteinID:
XP_010373447
UniProt:
A0A2K6RT65
LinkDB
All DBs
Position
20
AA seq
1265 aa
AA seq
DB search
MSTMVNVDSLAEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETRQVAWSKTADK
IEGFLDIMEIKEIRPGKNSKDFERAKAVRQKEDCCFTILYGTQFVLSTLSLAADSKEDAL
NWLSGLKILHQEAMSASTPTIIESWLRKQIYSVDQTRRNSISLRELKTILPLINFKVSSA
KFLKDKFVEIGAHKDELSFEQFHLFYKKLMFEQQKSILDEFKKDSSVFILGNTDRPDASA
VYLHDFQRFLIHEQQEHWAQDLSKVRERMTKFIDDTMRETAEPFLFVDEFLMYLFSRENS
IWDEKYDVVDMQDMNNPLSHYWISSSHNTYLTGDQLRSESSPEAYIRCLRMGCRCIELDC
WDGPDGKPVIYHGWTRTTKIKFDDVVQAIKDHAFVTSSFPVILSIEEHCSVEQQRHMAKT
FKEVFGDLLLMKPTEASADQLPSPSQLREKIIIKHKKLGPRGDVDVNVEDKKDEQKQQGE
LYMWDSIDQKWTRHYCAIADAKLSFSDDIEQTTEEEGPQDIPPTELHFGEKWFHKKVEKR
TSAEKLLQEYCMETGGKDGTFLVRESETFPNDYTLSFWRSGRVQHCRIRSTTEGGTLKYY
LTDNLTFSSIYALIQHYRETHLRCAEFELRLTDPVPNPNPHESKPWYYESLSRGEAEDML
MRIPRDGAFLIRKREGSDSYAITFRARGKVKHCRINRDGRHFVLGTSAYFESLVELVSYY
EKHSLYRKMRLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVKALYDY
KAKQSDELSFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTADVEELEKQII
EDNPLGSLCRGILDLNTYNVVKAPQGKNQKPFVFILEPKKQGDPPVEFATDRVEELFEWF
QSIREITWKIDTKENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVE
TKADSISRQKPVDLLRYNQKGLTRVYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTADKF
MQMNHALFSLNGRTGYVLQPESMRTEKYDPMPPESQRKILMTLTVKVLGARHLPKLGRSI
ACPFVEVEICGADYDNNKFKTTVVNDNGLSPIWAPTQEKVTFEIYDPNLAFLRFVVYEED
MFSDPNFLAHATYPIKAIKSGFRSVPLKNGYSEDIELASLLVFCEMRPVLESEEELYSSC
RQLRRRQEELNNQLFLYDTHQNLRNANRDALVKEFNVNENQLQLYQEKCNKRLREKRVSN
SKFYS
NT seq
3798 nt
NT seq
+upstream
nt +downstream
nt
atgtccactatggtcaatgtggattcccttgcggaatatgagaagagccagatcaagaga
gccctggagctggggacggtgatgactgtgttcagcttccgcaagtccacccctgagcgg
aggaccgtccaggtgatcatggagacgcggcaggtggcctggagcaagaccgctgacaag
atcgagggcttcttggatatcatggaaataaaagaaatccgcccagggaagaactccaaa
gattttgaacgtgcaaaagcagttcgccagaaagaagattgctgcttcaccatcctgtat
ggcactcagttcgtcctcagcacactcagcttggcagctgactctaaagaagacgcactt
aattggctctctggcttgaaaatcttacaccaagaagcgatgagtgcgtccacacccacc
attatcgagagttggctgagaaagcagatatattctgtggatcaaaccagaagaaacagc
atcagtctccgagagttgaagaccatcttgcccctgatcaactttaaagtgagcagtgcc
aagttccttaaagataagtttgtggaaataggagcacacaaagatgagctcagctttgaa
cagttccatctcttctataaaaaacttatgtttgagcagcaaaaatcgattctcgatgaa
ttcaaaaaggattcgtccgtgttcatcctggggaacactgacaggccggatgcctccgct
gtttacctgcatgacttccagaggtttctcatacatgaacagcaggagcattgggctcag
gatctgagcaaagtccgtgagcggatgacaaagttcatcgatgacaccatgcgtgaaact
gctgagcctttcttgtttgtggatgagttcctcatgtacctgttttcacgagaaaacagc
atctgggatgagaagtatgacgtggtggacatgcaggacatgaacaaccccttgtctcat
tactggatctcctcgtcacataacacgtacctcacaggtgaccagctgcggagcgagtcg
tccccggaagcttacatccgctgcctgcgcatgggctgtcgctgcattgaactggactgc
tgggacgggcctgatgggaagccggtcatctaccacggctggacgcggaccaccaagatc
aagtttgatgacgtcgtacaggccatcaaagaccacgcctttgttacctcaagcttccca
gtgatcctgtccatcgaggagcactgcagcgtggagcagcagcgtcacatggccaagacc
ttcaaggaagtgtttggcgacctgctgctgatgaagcccacggaggccagcgctgaccag
ctgccctcgcccagccagctgcgggagaagatcatcatcaagcacaagaagctgggtccc
cgaggcgacgtggatgtcaacgtggaggacaagaaggatgagcagaagcaacagggagag
ctgtacatgtgggattccatcgaccagaaatggactcggcactactgcgccattgccgac
gccaagctgtccttcagtgatgacattgaacagactacggaggaggaagggccccaggat
ataccccctacagagctacattttggggagaaatggttccacaagaaggtggagaagagg
acgagtgccgagaagttgctgcaggaatactgcatggagacagggggcaaggacggcacc
ttcctggttcgggagagcgagaccttccccaatgactacaccctgtccttctggcggtca
ggccgggtccagcactgccggatccgttccaccacggagggtggaaccctgaagtactac
ctgactgacaacctcaccttcagcagcatctacgccctcatccagcactaccgcgagacg
cacctgcgctgcgccgagtttgagttgcggctcacggaccctgtgcccaaccccaacccc
cacgagtccaagccgtggtactatgagagcctgagccgcggagaggcagaggacatgctg
atgaggatcccccgggacggagccttcctgatccggaagcgagagggaagcgactcctat
gccatcaccttcagggctaggggcaaggtgaagcattgtcgcatcaaccgggatggccgg
cactttgtgctggggacctctgcctattttgagagtctggtggagctcgtcagttactac
gagaagcattcactctaccgaaagatgagactgcgctatcccgtgacccccgagctcctg
gagcgctacaacatggaaagagatataaactccctctacgatgtcagcagaatgtatgtg
gatcccagtgaaatcaatccgtccatgcctcagagaaccgtgaaagctctgtatgactac
aaagccaagcaaagcgatgagctgagcttctgccgcggtgccctcatccacaatgtctcc
aaggagcccgggggctggtggaaaggagactatggaaccaggatccagcagtacttccca
tccaactacgtcgaggacatctcaactgcagatgttgaggagctggaaaaacagattatt
gaagacaatcccttagggtctctttgcagaggaatattggacctcaacacctataacgtc
gtgaaagccccacagggaaaaaaccagaagccctttgtctttatcctggagcccaagaag
cagggcgaccctccggtggagtttgccacagacagggtggaggagctcttcgagtggttt
cagagcatccgagagatcacctggaagattgacaccaaggagaacaacatgaagtactgg
gagaagaaccagtccatcgccatcgagctctctgatctggtggtctactgcaaaccaacc
agcaaaaccaaggacaacttagaaaatcctgacttccgagaaatccgctcctttgtggag
acgaaggctgacagcatcagcaggcagaagcccgtcgacctcctgaggtacaatcaaaag
ggcctgacccgcgtctacccaaagggacaaagagttgactcttcaaactacgaccccttc
cgcctctggctgtgcggttctcagatggtggcactcaatttccagacggcagataagttc
atgcagatgaatcacgcgctgttttctctcaatgggcgcacgggctacgttctgcagcct
gagagcatgaggacagagaaatatgacccaatgccacccgagtcccagaggaagatcctg
atgacgctgacggtcaaggttctcggtgctcgccatctccccaaacttggacgaagtatt
gcctgtccctttgtagaggtagagatctgtggcgccgactatgacaacaacaagttcaag
acgacggttgtgaatgataatggcctcagccctatctgggctccaacacaggagaaggtg
acatttgaaatttatgacccaaacctggcatttctgcgctttgtggtttacgaagaagat
atgttcagtgatcccaactttcttgctcatgccacttaccccattaaagcaatcaaatca
ggattcaggtctgttcctctgaagaatgggtacagcgaggacatagagctggcttccctc
ctggttttctgtgagatgcggccagtcctggagagcgaagaggaactttactcctcctgt
cgccagctaaggaggcggcaagaagaactgaacaaccagctctttctgtatgacacacac
cagaacttgcgcaatgccaaccgggatgccctggttaaagagttcaatgttaatgagaac
cagctccagctgtaccaggagaaatgcaacaagaggttaagagagaagagagtcagcaac
agcaagttttactcatag
Rhinopithecus roxellana (golden snub-nosed monkey): 104672220
Help
Entry
104672220 CDS
T03989
Gene name
PLCG1
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
rro
Rhinopithecus roxellana (golden snub-nosed monkey)
Pathway
rro00562
Inositol phosphate metabolism
rro01100
Metabolic pathways
rro01521
EGFR tyrosine kinase inhibitor resistance
rro04012
ErbB signaling pathway
rro04014
Ras signaling pathway
rro04015
Rap1 signaling pathway
rro04020
Calcium signaling pathway
rro04062
Chemokine signaling pathway
rro04064
NF-kappa B signaling pathway
rro04066
HIF-1 signaling pathway
rro04070
Phosphatidylinositol signaling system
rro04072
Phospholipase D signaling pathway
rro04360
Axon guidance
rro04370
VEGF signaling pathway
rro04613
Neutrophil extracellular trap formation
rro04650
Natural killer cell mediated cytotoxicity
rro04658
Th1 and Th2 cell differentiation
rro04659
Th17 cell differentiation
rro04660
T cell receptor signaling pathway
rro04664
Fc epsilon RI signaling pathway
rro04666
Fc gamma R-mediated phagocytosis
rro04670
Leukocyte transendothelial migration
rro04722
Neurotrophin signaling pathway
rro04750
Inflammatory mediator regulation of TRP channels
rro04919
Thyroid hormone signaling pathway
rro04933
AGE-RAGE signaling pathway in diabetic complications
rro04935
Growth hormone synthesis, secretion and action
rro05012
Parkinson disease
rro05022
Pathways of neurodegeneration - multiple diseases
rro05135
Yersinia infection
rro05167
Kaposi sarcoma-associated herpesvirus infection
rro05170
Human immunodeficiency virus 1 infection
rro05171
Coronavirus disease - COVID-19
rro05200
Pathways in cancer
rro05205
Proteoglycans in cancer
rro05206
MicroRNAs in cancer
rro05214
Glioma
rro05223
Non-small cell lung cancer
rro05225
Hepatocellular carcinoma
rro05231
Choline metabolism in cancer
rro05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Module
rro_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
rro00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
104672220 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
104672220 (PLCG1)
04014 Ras signaling pathway
104672220 (PLCG1)
04015 Rap1 signaling pathway
104672220 (PLCG1)
04370 VEGF signaling pathway
104672220 (PLCG1)
04064 NF-kappa B signaling pathway
104672220 (PLCG1)
04066 HIF-1 signaling pathway
104672220 (PLCG1)
04020 Calcium signaling pathway
104672220 (PLCG1)
04070 Phosphatidylinositol signaling system
104672220 (PLCG1)
04072 Phospholipase D signaling pathway
104672220 (PLCG1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
104672220 (PLCG1)
04650 Natural killer cell mediated cytotoxicity
104672220 (PLCG1)
04660 T cell receptor signaling pathway
104672220 (PLCG1)
04658 Th1 and Th2 cell differentiation
104672220 (PLCG1)
04659 Th17 cell differentiation
104672220 (PLCG1)
04664 Fc epsilon RI signaling pathway
104672220 (PLCG1)
04666 Fc gamma R-mediated phagocytosis
104672220 (PLCG1)
04670 Leukocyte transendothelial migration
104672220 (PLCG1)
04062 Chemokine signaling pathway
104672220 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
104672220 (PLCG1)
04919 Thyroid hormone signaling pathway
104672220 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
104672220 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
104672220 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
104672220 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
104672220 (PLCG1)
05206 MicroRNAs in cancer
104672220 (PLCG1)
05205 Proteoglycans in cancer
104672220 (PLCG1)
05231 Choline metabolism in cancer
104672220 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
104672220 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
104672220 (PLCG1)
05214 Glioma
104672220 (PLCG1)
05223 Non-small cell lung cancer
104672220 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
104672220 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
104672220 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
104672220 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
104672220 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
104672220 (PLCG1)
05171 Coronavirus disease - COVID-19
104672220 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
104672220 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
104672220 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
rro04131
]
104672220 (PLCG1)
Enzymes [BR:
rro01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
104672220 (PLCG1)
Membrane trafficking [BR:
rro04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
104672220 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
104672220 (PLCG1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
PH
SH3_9
SH3_2
PH_12
GDPD
PH_9
Motif
Other DBs
NCBI-GeneID:
104672220
NCBI-ProteinID:
XP_010374254
UniProt:
A0A2K6Q7Y9
LinkDB
All DBs
Position
13
AA seq
1291 aa
AA seq
DB search
MAGAASPCANGCGPGAPSDAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQI
TWSRGADKIEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTL
SLQATSEDEVNMWIKGLTWLMEDTLQAPTPLQIERWLRKQFYSVDRNREDRISAKDLKNM
LSQVNYRVPNMRFLRERLTDLEQRSGDITYGQFAQLYRSLMYSAQKTMDLPFLEASTLRA
GERPELCRVSLPEFQQFLLDYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVT
FLFSKENSVWNSQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMG
CRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLQTIKEHAFVASEYPVILSIEDHCSIA
QQRNMAQHFKKVLGDTLLTKPVEISADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSMM
YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEVSS
STELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFW
RNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQT
NAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE
GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNP
GFYVEANPMPTFKCAVKALFDYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLW
FPSNYVEEMVNPVALEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSIS
MASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKIMERRKKIALELSELVVYC
RPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDS
SNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMTGRHCGYVLQPSTMRDEAFDPFDKS
SLRGLEPCAISVEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPVW
PAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATYPVKGLKTGYRAVPLKNNYSEDL
ELASLLIKIDIFPAKQENGDLSPFSGTSLRERGSDASGQLFHGRAREGSFESRYQQPFED
FRISQEHLADHFDSRERRAPRRTRVNGDNRL
NT seq
3876 nt
NT seq
+upstream
nt +downstream
nt
atggcgggcgccgcgtccccctgcgccaacggctgcgggcccggcgcgccctcggacgcc
gaggtgctgcacctctgccgcagcctcgaggtgggcaccgtcatgactttgttctactcc
aagaagtcgcagcgacccgagcggaagaccttccaggtcaagctggagacgcgccagatc
acgtggagccggggcgccgacaagatagagggggccattgatattcgtgaaatcaaggag
atccgcccagggaagacctcacgggactttgatcgctatcaagaggaccccgctttccgg
ccggaccagtcacactgctttgtcattctctatggaatggaattccgcctgaagacgctg
agcctgcaagccacatctgaggatgaagtgaacatgtggatcaagggcttaacttggctg
atggaggatactttgcaggcacccacacccctgcagattgagaggtggctccggaagcag
ttttactcagtggatcggaatcgtgaggatcgtatatcagccaaggacctaaagaacatg
ctgtcccaggtcaactaccgggtccccaacatgcgcttcctccgagagcggctgacggac
ctggagcagcgcagcggggacatcacctacgggcagtttgctcagctgtaccgcagcctc
atgtacagcgcccagaagacgatggacctccccttcttggaagccagtactctgagggct
ggggagcggccggagctttgccgagtgtcccttcctgagttccagcagttccttcttgac
taccagggggagctgtgggctgttgatcgcctccaggtgcaggagttcatgctcagcttc
ctccgagaccccttgcgagagatcgaggagccatacttcttcctggatgagtttgtcacc
ttcctgttctccaaagagaatagtgtgtggaactcgcagctggatgcagtatgcccggac
accatgaacaaccccctttcccactattggatctcttcctcacacaacacgtacctgacc
ggggaccagttctccagtgagtcctccttggaagcctatgctcgctgcctgcggatgggc
tgtcgctgcattgagttggactgctgggacggcccagatgggatgccagttatttaccat
gggcacacccttaccaccaagatcaagttctcagatgtcctgcaaaccatcaaggagcat
gcctttgtggcctcagagtacccagtcatcctgtccattgaggaccactgcagcattgcc
cagcagaggaacatggcccagcacttcaagaaggtgctaggggacacactcctcaccaag
cccgtggagatctccgctgatgggctcccctcacccaaccagcttaagaggaagatcctc
atcaagcacaagaagctggcggagggcagtgcctacgaggaggtgcctacatccatgatg
tactctgagaacgacatcagcaactccatcaagaatggcatcctctacctggaggaccct
gtgaaccacgaatggtatccccactacttcgttctgaccagcagcaagatctactactct
gaggagaccagcagtgaccagggcaacgaggatgaggaggagcccaaggaggtcagcagc
agcacagagctgcactccaatgagaagtggttccatgggaagctaggggcagggcgtgac
gggcggcacatcgctgagcgcctgctcactgagtactgcatcgagaccggggcccctgac
ggctccttcctcgtgcgagagagtgagaccttcgtgggcgactacacgctctctttctgg
cggaatgggaaagtccagcactgccgtatccactcacggcaagatgctgggacccccaag
ttcttcttgacagacaacctcgtctttgactccctctatgacctcatcacacactaccag
caggtgcctctgcgctgcaatgagtttgagatgcgactttcagagcctgtcccacagacg
aatgcccacgagagcaaagagtggtaccacgcgagcctgaccagagcacaggctgagcac
atgctgatgcgtgtccctcgtgatggggccttcctggtgcggaagcggaatgagcccaac
tcatatgccatctctttccgggctgaaggcaagatcaagcattgccgtgtccagcaagag
ggccagactgtgatgctagggaactcggagttcgacagccttgttgacctcatcagctac
tatgagaagcacccgctataccgcaagatgaaactgcgctatcccatcaacgaggaggcg
ctggagaagattggcacagctgagcctgactacggggccctgtatgagggacgcaaccct
ggcttctatgtagaggcaaaccctatgccaactttcaagtgtgcagtcaaagctctcttt
gactacaaggcccagagagaggatgagctgaccttcaccaagagcgccatcatccagaat
gtggagaagcaagagggaggctggtggcgaggggactacggagggaagaagcagctgtgg
ttcccatcaaactacgtggaagagatggtcaaccccgtggccctggagccagagagggag
cacttggacgagaacagccccctaggggacttgctgcggggggtcttggatgtgccggct
tgtcagattgccatccgtcctgagggcaagaacaaccggctcttcgtcttctccatcagc
atggcgtcggtggcccactggtccctggatgttgctgctgactcacaggaggagctgcag
gactgggtgaaaaagatccgtgaagtggcccagaccgcagatgccaggctcactgaaggg
aagataatggaacggaggaagaagatcgccctggagctctctgaacttgttgtctactgc
cggcctgttcccttcgatgaagagaagattggcacagaacgtgcttgctaccgggacatg
tcatccttcccggaaaccaaggctgagaaatacgtgaacaaggccaaaggcaagaagttc
cttcagtacaatcgactgcagctctcccgcatctaccccaagggccagcgactggattcc
tccaactacgatcctttgcccatgtggatctgtggcagtcagctggtggccctcaacttc
cagacccctgacaagcctatgcagatgaaccaggctctcttcatgacgggcaggcactgt
ggctacgtgctgcagccaagcaccatgcgggatgaggccttcgacccctttgacaagagc
agcctccgcgggctggagccatgtgccatctctgttgaggtgctgggtgccagacatttg
ccaaagaatggccgaggcattgtgtgcccttttgtggagattgaggtggctggagctgag
tatgacagcaccaagcagaagacagagtttgtggtggacaatggactcaaccctgtatgg
ccggccaagcccttccacttccagatcagtaaccctgaatttgcctttctgcgctttgtg
gtgtatgaggaagacatgtttagtgaccagaatttcctggctcaggctacttacccggta
aaaggcctgaagacaggatacagagcagtgcctttgaagaacaactacagtgaggacctg
gagttggcctccctgctgatcaagattgacattttccctgccaagcaggagaatggtgac
ctcagtcccttcagtggtacgtccctgcgggagcggggctcagatgcctcaggccagctg
tttcacggccgagcccgggaaggctcctttgaatcccgctaccagcagccatttgaggac
ttccgcatctcccaggagcatcttgcagaccattttgacagtcgagaacgaagggcccca
agaaggactcgggtcaatggagacaaccgcctctag
DBGET
integrated database retrieval system